Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
Author:
Affiliation:
1. Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), University of Oxford, Oxford, UK
2. Centre National de Génotypage, Institut Genomique, Commissariat à l’énergie Atomique, Evry, France
Publisher
Oxford University Press (OUP)
Subject
Cardiology and Cardiovascular Medicine
Link
http://academic.oup.com/eurheartj/article-pdf/34/13/982/17154099/ehs344.pdf
Reference33 articles.
1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Cholesterol Treatment Trialists’ (CTT) Collaboration;Lancet,2010
2. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study);Jones;Am J Cardiol,1998
3. Clinical implications of pharmacogenomics of statin treatment;Mangravite;Pharmacogenomics J,2006
4. Genome-wide association of lipid-lowering response to statins in combined study populations;Barber;PLoS One,2010
5. Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial;Chasman;Circ Cardiovasc Genet,2012
Cited by 91 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test;Pharmacological Reviews;2024-08-09
2. Leveraging large-scale biobank EHRs to enhance pharmacogenetics of cardiometabolic disease medications;2024-04-07
3. When the same treatment has different response: The role of pharmacogenomics in statin therapy;Biomedicine & Pharmacotherapy;2024-01
4. Association between SORT1/CELSR2/PSRC1 rs646776 polymorphism and statin-affected plasma lipid levels;Biomedical Research and Therapy;2023-12-31
5. Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society;Atherosclerosis;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3